<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37367456</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2313-433X</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>28</Day></PubDate></JournalIssue><Title>Journal of imaging</Title><ISOAbbreviation>J Imaging</ISOAbbreviation></Journal><ArticleTitle>Transformative Effect of COVID-19 Pandemic on Magnetic Resonance Imaging Services in One Tertiary Cardiovascular Center.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">108</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jimaging9060108</ELocationID><Abstract><AbstractText>The aim of study was to investigate the transformative effect of the COVID-19 pandemic on magnetic resonance imaging (MRI) services in one tertiary cardiovascular center. The retrospective observational cohort study analyzed data of MRI studies (<i>n</i> = 8137) performed from 1 January 2019 to 1 June 2022. A total of 987 patients underwent contrast-enhanced cardiac MRI (CE-CMR). Referrals, clinical characteristics, diagnosis, gender, age, past COVID-19, MRI study protocols, and MRI data were analyzed. The annual absolute numbers and rates of CE-CMR procedures in our center significantly increased from 2019 to 2022 (<i>p</i>-value &lt; 0.05). The increasing temporal trends were observed in hypertrophic cardiomyopathy (HCMP) and myocardial fibrosis (<i>p</i>-value &lt; 0.05). The CE-CMR findings of myocarditis, acute myocardial infarction, ischemic cardiomyopathy, HCMP, postinfarction cardiosclerosis, and focal myocardial fibrosis prevailed in men compared with the corresponding values in women during the pandemic (<i>p</i>-value &lt; 0.05). The frequency of myocardial fibrosis occurrence increased from ~67% in 2019 to ~84% in 2022 (<i>p</i>-value &lt; 0.05). The COVID-19 pandemic increased the need for MRI and CE-CMR. Patients with a history of COVID-19 had persistent and newly occurring symptoms of myocardial damage, suggesting chronic cardiac involvement consistent with long COVID-19 requiring continuous follow-up.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shelkovnikova</LastName><ForeName>Tatiana A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Cardiology Research Institute, Branch of the Federal State Budgetary Scientific Institution "Tomsk National Research Medical Center of the Russian Academy of Sciences", 634012 Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maksimova</LastName><ForeName>Aleksandra S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Cardiology Research Institute, Branch of the Federal State Budgetary Scientific Institution "Tomsk National Research Medical Center of the Russian Academy of Sciences", 634012 Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryumshina</LastName><ForeName>Nadezhda I</ForeName><Initials>NI</Initials><AffiliationInfo><Affiliation>Cardiology Research Institute, Branch of the Federal State Budgetary Scientific Institution "Tomsk National Research Medical Center of the Russian Academy of Sciences", 634012 Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mochula</LastName><ForeName>Olga V</ForeName><Initials>OV</Initials><AffiliationInfo><Affiliation>Cardiology Research Institute, Branch of the Federal State Budgetary Scientific Institution "Tomsk National Research Medical Center of the Russian Academy of Sciences", 634012 Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaizov</LastName><ForeName>Valery K</ForeName><Initials>VK</Initials><AffiliationInfo><Affiliation>Cardiology Research Institute, Branch of the Federal State Budgetary Scientific Institution "Tomsk National Research Medical Center of the Russian Academy of Sciences", 634012 Tomsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ussov</LastName><ForeName>Wladimir Y</ForeName><Initials>WY</Initials><Identifier Source="ORCID">0000-0001-7978-5514</Identifier><AffiliationInfo><Affiliation>Cardiology Research Institute, Branch of the Federal State Budgetary Scientific Institution "Tomsk National Research Medical Center of the Russian Academy of Sciences", 634012 Tomsk, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Meshalkin National Medical Research Center, 630055 Novosibirsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anfinogenova</LastName><ForeName>Nina D</ForeName><Initials>ND</Initials><Identifier Source="ORCID">0000-0003-1106-0730</Identifier><AffiliationInfo><Affiliation>Cardiology Research Institute, Branch of the Federal State Budgetary Scientific Institution "Tomsk National Research Medical Center of the Russian Academy of Sciences", 634012 Tomsk, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>22-I5-00313</GrantID><Agency>The Russian Science Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Imaging</MedlineTA><NlmUniqueID>101698819</NlmUniqueID><ISSNLinking>2313-433X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CMR</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">electronic medical record</Keyword><Keyword MajorTopicYN="N">hypertrophic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">myocardial fibrosis</Keyword><Keyword MajorTopicYN="N">myocarditis</Keyword><Keyword MajorTopicYN="N">paramagnetic contrast-enhanced cardiac magnetic resonance imaging</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>13</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>10</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37367456</ArticleId><ArticleId IdType="pmc">PMC10299552</ArticleId><ArticleId IdType="doi">10.3390/jimaging9060108</ArticleId><ArticleId IdType="pii">jimaging9060108</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kelle S., Bucciarelli-Ducci C., Judd R.M., Kwong R.Y., Simonetti O., Plein S., Raimondi F., Weinsaft J.W., Wong T.C., Carr J. Society for Cardiovascular Magnetic Resonance (SCMR) recommended CMR protocols for scanning patients with active or convalescent phase COVID-19 infection. J. Cardiovasc. Magn. Reson. 2020;22:61. doi: 10.1186/s12968-020-00656-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-020-00656-6</ArticleId><ArticleId IdType="pmc">PMC7467754</ArticleId><ArticleId IdType="pubmed">32878639</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins V., Sohaei D., Diamandis E.P., Prassas I. COVID-19: From an acute to chronic disease? Potential long-term health consequences. Crit. Rev. Clin. Lab. Sci. 2020;58:297&#x2013;310. doi: 10.1080/10408363.2020.1860895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408363.2020.1860895</ArticleId><ArticleId IdType="pubmed">33347790</ArticleId></ArticleIdList></Reference><Reference><Citation>Ussov W.Y., Nudnov N.V., Ignatenko G.A., Fisenko A.Y., Gulyaev V.M., Maritskii S.V., Kalyuzhin V.V., Lukyanenok P.I. Evaluation of lung damage in pneumonia, from chest magnetic resonance imaging, in primary diagnosis and in the follow-up of treatment. Med. Vis. 2020;24:63&#x2013;77. doi: 10.24835/1607-0763-2020-2-63-77.</Citation><ArticleIdList><ArticleId IdType="doi">10.24835/1607-0763-2020-2-63-77</ArticleId></ArticleIdList></Reference><Reference><Citation>Ussov W.Y., Nudnov N.V., Ignatenko G.A., Gulyaev V.M., Pervak M.B., Shelkovnikova T.A., Dubovaya A.V., Bergen T.A. Primary and prospective imaging of the chest using magnetic resonance imaging in patients with viral lung damage in COVID-19. Med. Vis. 2020;24:11&#x2013;26. doi: 10.24835/1607-0763-2020-4-11-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.24835/1607-0763-2020-4-11-26</ArticleId></ArticleIdList></Reference><Reference><Citation>Todorovic V. Mild SARS-CoV-2 infection leaves long-lasting effects on cardiovascular health. Nat. Cardiovasc. Res. 2022;1:870. doi: 10.1038/s44161-022-00150-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s44161-022-00150-5</ArticleId><ArticleId IdType="pubmed">39195974</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadan M.S., Bertolino L., Zampino R., Durante-Mangoni E., Iossa D., Ursi M.P., D&#x2019;Amico F., Karruli A., Andini R., Bernardo M., et al. Cardiac sequelae after coronavirus disease 2019 recovery: A systematic review. Clin. Microbiol. Infect. 2021;27:1250&#x2013;1261. doi: 10.1016/j.cmi.2021.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.06.015</ArticleId><ArticleId IdType="pmc">PMC8220864</ArticleId><ArticleId IdType="pubmed">34171458</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansheles A.A., Sergienko V.B., Sinitsyn E.V., Vakhromeeva M.N., Kokov A.N., Zavadovsky K.V., Ryzhkova D.V., Karalkin A.V., Shurupova I.V., Pospelov V.A., et al. Analysis of the restoration of cardiology diagnostics scope in the Russian Federation during the COVID-19 pandemic: Results of the Russian segment of the INCAPS COVID 2 study under the auspices of the International Atomic Energy Agency. Russ. J. Cardiol. 2022;27:5170. doi: 10.15829/1560-4071-2022-5170. (In Russian)</Citation><ArticleIdList><ArticleId IdType="doi">10.15829/1560-4071-2022-5170</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudakov D.V., Sudakov O.V., Shevtsov A.N., Belov E.V., Androsova O.A. Analysis of complications among patients after previous new coronoviral COVID-19 infection. Syst. Anal. Manag. Biomed. Syst. 2021;20:15&#x2013;23. doi: 10.36622/VSTU.2021.20.1.002. (In Russian)</Citation><ArticleIdList><ArticleId IdType="doi">10.36622/VSTU.2021.20.1.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Italia L., Tomasoni D., Bisegna S., Pancaldi E., Stretti L., Adamo M., Metra M. COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae. Front. Cardiovasc. Med. 2021;8:713560. doi: 10.3389/fcvm.2021.713560.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.713560</ArticleId><ArticleId IdType="pmc">PMC8382715</ArticleId><ArticleId IdType="pubmed">34447795</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisun A.Y., Lobzin Y.V., Cherkashin D.V., Tyrenko V.V., Tkachenko K.N., Kachnov V.A., Kutelev G.G., Rudchenko I.V., Sobolev A.D. Mechanisms of Damage to the Cardiovascular System in COVID-19. Ann. Russ. Acad. Med. Sci. 2021;76:287&#x2013;297. doi: 10.15690/vramn1474.</Citation><ArticleIdList><ArticleId IdType="doi">10.15690/vramn1474</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobelev E., Bergen T.A., Tarkova A.R., Vasiltseva O.Y., Kamenskaya O.V., Usov V.Y., Chernyavsky A.M. COVID-19 as a cause of chronic pulmonary hypertension: Pathophysiological rationale and potential of instrumental investigations. Cardiovasc. Ther. Prev. 2021;20:2844. doi: 10.15829/1728-8800-2021-2844. (In Russian)</Citation><ArticleIdList><ArticleId IdType="doi">10.15829/1728-8800-2021-2844</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelkovnikova T.A., Pushnikova E.Y., Baev A.E., Ryabov V.V., Ussov W.Y. Magnetic resonance syndromes of myocardial damage in patients after new coronavirus infection (COVID-19)&#x2014;Two typical clinical cases. Sib. J. Clin. Exp. Med. 2022;37:135&#x2013;141. doi: 10.29001/2073-8552-2022-37-1-135-141. (In Russian)</Citation><ArticleIdList><ArticleId IdType="doi">10.29001/2073-8552-2022-37-1-135-141</ArticleId></ArticleIdList></Reference><Reference><Citation>Ussov W.Y., Ignatenko G.A., Nudnov N.V., Bergen T.A., Gulyaev V.M., Pervak M.B., Yaroshevsky S.P., Dubovaya A.V., Karmazanovsky G.G. Comprehensive MRI of the Chest and Brain in the Diagnosis of Injury to Thoracic Organs, Myocardium, and Brain in COVID-19.  [(accessed on 29 April 2023)]. pp. 144&#x2013;145. The University Clinic 2021. Available online:  https://dnmu.ru/wp-content/uploads/2021/02/materConfCovid_010221.pdf. (In Russian)</Citation></Reference><Reference><Citation>Baig A.M. Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers. J. Med. Virol. 2020;93:2555&#x2013;2556. doi: 10.1002/jmv.26624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26624</ArticleId><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Baden L.R., El Sahly H.M., Essink B., Kotloff K., Frey S., Novak R., Diemert D., Spector S.A., Rouphael N., Creech C.B., et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 2021;384:403&#x2013;416. doi: 10.1056/NEJMoa2035389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2035389</ArticleId><ArticleId IdType="pmc">PMC7787219</ArticleId><ArticleId IdType="pubmed">33378609</ArticleId></ArticleIdList></Reference><Reference><Citation>Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J.L., P&#xe9;rez Marc G., Moreira E.D., Zerbini C., et al. Safety and Efficacy of the BNT162b2 mRNA COVID-19 vaccine. N. Engl. J. Med. 2020;383:2603&#x2013;2615. doi: 10.1056/NEJMoa2034577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2034577</ArticleId><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidenreich P.A., Bozkurt B., Aguilar D., Allen L.A., Byun J.J., Colvin M.M., Deswal A., Drazner M.H., Dunlay S.M., Evers L.R., et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2022;79:e263&#x2013;e421. doi: 10.1016/j.jacc.2021.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.12.012</ArticleId><ArticleId IdType="pubmed">35379503</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen S.E., Friedrich M.G., Leiner T., Elias M.D., Ferreira V.M., Fenski M., Flamm S.D., Fogel M., Garg R., Halushka M.K., et al. Cardiovascular Magnetic Resonance for Patients with COVID-19. JACC Cardiovasc. Imaging. 2021;15:685&#x2013;699. doi: 10.1016/j.jcmg.2021.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2021.08.021</ArticleId><ArticleId IdType="pmc">PMC8514168</ArticleId><ArticleId IdType="pubmed">34656482</ArticleId></ArticleIdList></Reference><Reference><Citation>Ussov W.Y., Mochula O.V., Ryumshina N.I., Shelkovnikova T.A., Sukhareva A.E., Maksimova A.S., Velichko O.B., Vaizov V.K., Ovchinnikov P.P., Zavadovsky K.V., et al.  Certificate of the State Registration for Database No. 2022622669 Russian Federation. Register of Magnetic Resonance Imaging Studies: No. 2022622644: Submitted 24.10.2022: Published 28.10.2022; Applicant: Tomsk NRMC.&#x2014;EDN XWWUWA.  [(accessed on 29 April 2023)].  Available online:  https://www.elibrary.ru/download/elibrary_49774441_46558053.PDF.</Citation></Reference><Reference><Citation>De Pelsemaeker M.-C., Guiot Y., Vanderveken J., Galant C., Van Bockstal M.R. The Impact of the COVID-19 Pandemic and the Associated Belgian Governmental Measures on Cancer Screening, Surgical Pathology and Cytopathology. Pathobiology. 2021;88:46&#x2013;55. doi: 10.1159/000509546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000509546</ArticleId><ArticleId IdType="pmc">PMC7445376</ArticleId><ArticleId IdType="pubmed">32634799</ArticleId></ArticleIdList></Reference><Reference><Citation>Keizman E., Ram E., Kachel E., Sternik L., Raanani E. The impact of COVID-19 pandemic on cardiac surgery in Israel. J. Cardiothorac. Surg. 2020;15:294. doi: 10.1186/s13019-020-01342-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-020-01342-5</ArticleId><ArticleId IdType="pmc">PMC7530866</ArticleId><ArticleId IdType="pubmed">33008486</ArticleId></ArticleIdList></Reference><Reference><Citation>Saban M., Reznik A., Shachar T., Wilf-Miron R., Sivan-Hoffmann R. The effect of the COVID-19 pandemic on ED referrals and care for stroke patients: A four-year comparative study. J. Crit. Care. 2020;62:230&#x2013;234. doi: 10.1016/j.jcrc.2020.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2020.12.011</ArticleId><ArticleId IdType="pmc">PMC7832626</ArticleId><ArticleId IdType="pubmed">33453680</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartnett K.P., Kite-Powell A., DeVies J., Coletta M.A., Boehmer T.K., Adjemian J., Gundlapalli A.V. National Syndromic Surveillance Program Community of Practice Impact of the COVID-19 Pandemic on Emergency Department Visits&#x2014;United States, January 1, 2019&#x2013;May 30, 2020. MMWR. Morb. Mortal. Wkly. Rep. 2020;69:699&#x2013;704. doi: 10.15585/mmwr.mm6923e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6923e1</ArticleId><ArticleId IdType="pmc">PMC7315789</ArticleId><ArticleId IdType="pubmed">32525856</ArticleId></ArticleIdList></Reference><Reference><Citation>Anfinogenova N.D., Trubacheva I.A., Popov S.V., Efimova E.V., Ussov W.Y. Trends and concerns of potentially inappropriate medication use in patients with cardiovascular diseases. Expert Opin. Drug Saf. 2021;20:1191&#x2013;1206. doi: 10.1080/14740338.2021.1928632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14740338.2021.1928632</ArticleId><ArticleId IdType="pubmed">33970732</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattaneo D., Pasina L., Maggioni A.P., Oreni L., Conti F., Pezzati L., Casalini G., Bonazzetti C., Morena V., Ridolfo A., et al. Drug&#x2013;Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients. Drugs Aging. 2021;38:341&#x2013;346. doi: 10.1007/s40266-021-00840-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40266-021-00840-y</ArticleId><ArticleId IdType="pmc">PMC7917961</ArticleId><ArticleId IdType="pubmed">33646509</ArticleId></ArticleIdList></Reference><Reference><Citation>Vakili S., Savardashtaki A., Jamalnia S., Tabrizi R., Nematollahi M.H., Jafarinia M., Akbari H. Laboratory Findings of COVID-19 Infection are Conflicting in Different Age Groups and Pregnant Women: A Literature Review. Arch. Med. Res. 2020;51:603&#x2013;607. doi: 10.1016/j.arcmed.2020.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2020.06.007</ArticleId><ArticleId IdType="pmc">PMC7287430</ArticleId><ArticleId IdType="pubmed">32571605</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich M.G., Sechtem U., Schulz-Menger J., Holmvang G., Alakija P., Cooper L.T., White J.A., Abdel-Aty H., Gutberlet M., Prasad S., et al. Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper. J. Am. Coll. Cardiol. 2009;53:1475&#x2013;1487. doi: 10.1016/j.jacc.2009.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2009.02.007</ArticleId><ArticleId IdType="pmc">PMC2743893</ArticleId><ArticleId IdType="pubmed">19389557</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagan J., Schmitt M., Miller C.A. Clinical applications of multi-parametric CMR in myocarditis and systemic inflammatory diseases. Int. J. Cardiovasc. Imaging. 2017;34:35&#x2013;54. doi: 10.1007/s10554-017-1063-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10554-017-1063-9</ArticleId><ArticleId IdType="pmc">PMC5797564</ArticleId><ArticleId IdType="pubmed">28130644</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori C., Farina D., Vaccher F., Ferrandino G., Bellini D., Carbone I. Myocarditis: Imaging up to date. La Radiol. Med. 2020;125:1124&#x2013;1134. doi: 10.1007/s11547-020-01279-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11547-020-01279-8</ArticleId><ArticleId IdType="pmc">PMC7538190</ArticleId><ArticleId IdType="pubmed">33025305</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit N.M., Churchill A., Nsair A., Hsu J.J. Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known? Am. Heart J. Plus: Cardiol. Res. Pract. 2021;5:100025. doi: 10.1016/j.ahjo.2021.100025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahjo.2021.100025</ArticleId><ArticleId IdType="pmc">PMC8223036</ArticleId><ArticleId IdType="pubmed">34192289</ArticleId></ArticleIdList></Reference><Reference><Citation>Awortwe C., Cascorbi I. Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions. Pharmacol. Res. 2020;161:105250. doi: 10.1016/j.phrs.2020.105250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.105250</ArticleId><ArticleId IdType="pmc">PMC7550259</ArticleId><ArticleId IdType="pubmed">33059010</ArticleId></ArticleIdList></Reference><Reference><Citation>Ignatenko G.A., Pervak M.B., Usov V.Y., Dubovaya A.V., Gerasimenko V.V. Computed-tomographic evaluation of the lung changes in COVID-19 after 4&#x2013;6 months: Comparison with the results of the study in the acute period of the disease and clinical data.  [(accessed on 29 April 2023)];Arch. Clin. Exp. Med. 2022 31:112&#x2013;118. Available online:  https://portal.dnmu.ru/fileadmin/EDITDATA/bibl/AKEHM_2022_No2.pdf.</Citation></Reference><Reference><Citation>Wojtowicz D., Dorniak K., &#x141;awrynowicz M., W&#x105;&#x17c; P., Fija&#x142;kowska J., Kulawiak-Ga&#x142;&#x105;ska D., Rejszel-Baranowska J., Knut R., Haberka M., Szurowska E., et al. Cardiac Magnetic Resonance Findings in Patients Recovered from COVID-19 Pneumonia and Presenting with Persistent Cardiac Symptoms: The TRICITY-CMR Trial. Biology. 2022;11:1848. doi: 10.3390/biology11121848.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology11121848</ArticleId><ArticleId IdType="pmc">PMC9775441</ArticleId><ArticleId IdType="pubmed">36552357</ArticleId></ArticleIdList></Reference><Reference><Citation>Kersten J., Baumhardt M., Hartveg P., Hoyo L., H&#xfc;ll E., Imhof A., Kropf-Sanchen C., Nita N., M&#xf6;rike J., Rattka M., et al. Long COVID: Distinction between Organ Damage and Deconditioning. J. Clin. Med. 2021;10:3782. doi: 10.3390/jcm10173782.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10173782</ArticleId><ArticleId IdType="pmc">PMC8432179</ArticleId><ArticleId IdType="pubmed">34501230</ArticleId></ArticleIdList></Reference><Reference><Citation>Camastra G., Arcari L., Ciolina F., Danti M., Ansalone G., Cacciotti L., Sbarbati S. Characterization of COVID-19-Related Lung Involvement in Patients Undergoing Magnetic Resonance T1 and T2 Mapping Imaging: A Pilot Study. J. Imaging. 2022;8:314. doi: 10.3390/jimaging8120314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jimaging8120314</ArticleId><ArticleId IdType="pmc">PMC9781162</ArticleId><ArticleId IdType="pubmed">36547479</ArticleId></ArticleIdList></Reference><Reference><Citation>Drakos S., Chatzantonis G., Bietenbeck M., Evers G., Schulze A.B., Mohr M., Fonfara H., Meier C., Yilmaz A. A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients. Sci. Rep. 2021;11:15667. doi: 10.1038/s41598-021-95277-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95277-z</ArticleId><ArticleId IdType="pmc">PMC8329060</ArticleId><ArticleId IdType="pubmed">34341436</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeboye A., Alkhatib D., Butt A., Yedlapati N., Garg N. A Review of the Role of Imaging Modalities in the Evaluation of Viral Myocarditis with a Special Focus on COVID-19-Related Myocarditis. Diagnostics. 2022;12:549. doi: 10.3390/diagnostics12020549.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12020549</ArticleId><ArticleId IdType="pmc">PMC8870822</ArticleId><ArticleId IdType="pubmed">35204637</ArticleId></ArticleIdList></Reference><Reference><Citation>Mester A., Benedek I., Rat N., Tolescu C., Polexa S.A., Benedek T. Imaging Cardiovascular Inflammation in the COVID-19 Era. Diagnostics. 2021;11:1114. doi: 10.3390/diagnostics11061114.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11061114</ArticleId><ArticleId IdType="pmc">PMC8233709</ArticleId><ArticleId IdType="pubmed">34207266</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanghvi S.K., Schwarzman L.S., Nazir N.T. Cardiac MRI and Myocardial Injury in COVID-19: Diagnosis, Risk Stratification and Prognosis. Diagnostics. 2021;11:130. doi: 10.3390/diagnostics11010130.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11010130</ArticleId><ArticleId IdType="pmc">PMC7830889</ArticleId><ArticleId IdType="pubmed">33467705</ArticleId></ArticleIdList></Reference><Reference><Citation>Das B.B. SARS-CoV-2 Myocarditis in a High School Athlete after COVID-19 and Its Implications for Clearance for Sports. Children. 2021;8:427. doi: 10.3390/children8060427.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children8060427</ArticleId><ArticleId IdType="pmc">PMC8223786</ArticleId><ArticleId IdType="pubmed">34063781</ArticleId></ArticleIdList></Reference><Reference><Citation>Artico J., Shiwani H., Moon J.C., Gorecka M., McCann G.P., Roditi G., Morrow A., Mangion K., Lukaschuk E., Shanmuganathan M., et al. Myocardial Involvement After Hospitalization for COVID-19 Complicated by Troponin Elevation: A Prospective, Multicenter, Observational Study. Circulation. 2023;147:364&#x2013;374. doi: 10.1161/CIRCULATIONAHA.122.060632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.060632</ArticleId><ArticleId IdType="pmc">PMC9889203</ArticleId><ArticleId IdType="pubmed">36705028</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan O.K.A., Sheng C.C., Wang T.K.M., Cremer P.C. SARS-CoV-2 Myocarditis: Insights Into Incidence, Prognosis, and Therapeutic Implications. Curr. Cardiol. Rep. 2021;23:129. doi: 10.1007/s11886-021-01551-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-021-01551-x</ArticleId><ArticleId IdType="pmc">PMC8330199</ArticleId><ArticleId IdType="pubmed">34342728</ArticleId></ArticleIdList></Reference><Reference><Citation>Seidel F., Kuehne T., Kelle S., Doeblin P., Zieschang V., Tschoepe C., Al-Wakeel-Marquard N., Nordmeyer S. Cardiovascular magnetic resonance findings in non-hospitalized paediatric patients after recovery from COVID-19. ESC Heart Fail. 2021;8:5583&#x2013;5588. doi: 10.1002/ehf2.13678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13678</ArticleId><ArticleId IdType="pmc">PMC8652950</ArticleId><ArticleId IdType="pubmed">34704672</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubacek J. Effects of Selected Inherited Factors on Susceptibility to SARS-CoV-2 Infection and COVID-19 Progression. Physiol. Res. 2021;70((Suppl. S2)):S125&#x2013;S134. doi: 10.33549/physiolres.934730.</Citation><ArticleIdList><ArticleId IdType="doi">10.33549/physiolres.934730</ArticleId><ArticleId IdType="pmc">PMC8884368</ArticleId><ArticleId IdType="pubmed">34913347</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Liu B., Zhang S., Huang N., Zhao T., Lu Q., Cui F. Differences in incidence and fatality of COVID-19 by SARS-CoV-2 Omicron variant versus Delta variant in relation to vaccine coverage: A world-wide review. J. Med. Virol. 2022;95:e28118. doi: 10.1002/jmv.28118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28118</ArticleId><ArticleId IdType="pmc">PMC9537802</ArticleId><ArticleId IdType="pubmed">36056540</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>